(RTTNews) - Kymera Therapeutics, Inc. (KYMR) announced that the first patient has been dosed in its BREADTH Phase 2b clinical trial evaluating KT-621, an oral, highly selective degrader of STAT6, in ...

Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

S&P 500 breaks 6,900 despite weakest market breadth for a positive session since 1990. AI megacaps drive record highs while most stocks decline. Analysts say crypto’s real utility growth could outlast ...

Just 11% of U.S. consumers trust the first tool they use when searching online. That means nearly 9 in 10 Americans double-check or expand their search elsewhere “because they don’t trust the first ...

The real estate industry is at an inflection point. Affordability has become the single most pressing issue for consumers, regulators, and professionals alike. For decades, buyers searched by list ...

Investor confidence is growing in companies both big and small, providing a crucial pillar of support for Wall Street traders ahead of what’s typically been a challenging month for stocks.

When you think of a search and rescue animal, most people’s thoughts turn to dogs. Dogs have proven themselves to be highly trainable and effective at locating human scents, helping rescue teams ...

Maddy has a degree in biochemistry from the University of York and specializes in reporting on health, medicine, and genetics. Maddy has a degree in biochemistry from the University of York and ...

Alli McCartney, UBS managing director, joins 'Power Lunch' to discuss the market's current standing, how to avoid value traps and much more. Got a confidential news tip? We want to hear from you. Sign ...

As the hours go by, the work does not let up for the hundreds who are searching around the clock for the victims still missing from the Central Texas floods, including an international group of first ...